Filing Details
- Accession Number:
- 0001104659-21-035159
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-11 21:09:16
- Reporting Period:
- 2021-03-09
- Accepted Time:
- 2021-03-11 21:09:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1124524 | Cryoport Inc. | CYRX | Pharmaceutical Preparations (2834) | 880313393 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1848218 | W Mark Sawicki | C/O Cryoport Inc. 112 Westwood Place, Suite 350 Brentwood TN 37027 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-10 | 11,342 | $3.07 | 30,342 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-03-10 | 7,231 | $1.87 | 37,573 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-03-10 | 11,831 | $3.21 | 49,404 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-10 | 3,974 | $54.65 | 45,430 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-10 | 9,357 | $55.33 | 36,073 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option to purchase common stock | Acquisiton | 2021-03-09 | 21,333 | $0.00 | 21,333 | $58.94 |
Common Stock | Restricted Stock Rights | Acquisiton | 2021-03-09 | 10,667 | $0.00 | 10,667 | $0.00 |
Common Stock | Options to purchase common stock | Disposition | 2021-03-10 | 11,342 | $0.00 | 11,342 | $3.07 |
Common Stock | Options to purchase common stock | Disposition | 2021-03-10 | 11,831 | $0.00 | 11,831 | $3.21 |
Common Stock | Options to purchase common stock | Disposition | 2021-03-10 | 7,231 | $0.00 | 7,231 | $1.87 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
21,333 | 2028-03-09 | No | 4 | A | Direct | |
10,667 | No | 4 | A | Direct | ||
0 | 2025-08-20 | No | 4 | M | Direct | |
0 | 2021-05-18 | No | 4 | M | Direct | |
0 | 2026-05-06 | No | 4 | M | Direct |
Footnotes
- 1/48 of options vest on the 9th of each month for forty-eight months beginning 4/09/2021.
- Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
- The restricted stock rights vest in four equal annual installments beginning 3/9/2022.
- 1/48th of the 77,625 options originally granted vested on the 7th of each month for forty-eight months beginning June 7, 2015.
- 1/48th of the 78,000 options originally granted vested on the 18th of each month for forty-eight months beginning June 18, 2017.
- 1/48th of the 70,000 options originally granted vested on the 6th of each month for forty-eight months beginning June 6, 2016.